BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 166 filers reported holding BLUEBIRD BIO INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $39,456,000 | -20.6% | 221,541 | -38.8% | 0.40% | -29.4% |
| Q3 2017 | $49,697,000 | +9.9% | 361,825 | -15.9% | 0.56% | +0.9% |
| Q2 2017 | $45,220,000 | +21.5% | 430,462 | +5.2% | 0.56% | +10.2% |
| Q1 2017 | $37,205,000 | +33.0% | 409,295 | -9.7% | 0.51% | +14.9% |
| Q4 2016 | $27,972,000 | +4.0% | 453,354 | +14.2% | 0.44% | -9.6% |
| Q3 2016 | $26,902,000 | +10.9% | 396,897 | -29.1% | 0.49% | -0.4% |
| Q2 2016 | $24,249,000 | +14.1% | 560,164 | +12.0% | 0.49% | +4.0% |
| Q1 2016 | $21,261,000 | +33.3% | 500,253 | +101.4% | 0.47% | +8.3% |
| Q4 2015 | $15,948,000 | +5636.7% | 248,328 | +14950.2% | 0.44% | +6128.6% |
| Q2 2015 | $278,000 | -41.4% | 1,650 | -86.6% | 0.01% | -50.0% |
| Q2 2014 | $474,000 | – | 12,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
| Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
| ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
| EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
| Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
| APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
| Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
| PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |